NCT05898854View on ClinicalTrials.gov

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

September 30, 2035

Conditions
Gastric CancerGastro Esophageal Junctional CancerCancer
Interventions
DRUG

68Ga-FAPi-46

Gastric or gatro-esophageal junction cancer patients undergo 68Ga-FAPi-46 PET/CT at primary staging and at restaging

Trial Locations (1)

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER

NCT05898854 - [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer | Biotech Hunter | Biotech Hunter